No Data
No Data
ORNA Reports FY24Q3 Attributable Profit of RM1.1 Million, Down 21.4% YoY
ORNA: Quarterly rpt on consolidated results for the financial period ended 30/09/2024
Orna Therapeutics Unveils Novel In Vivo Gene Editing Data Highlighting Engineering and Delivery Approach at the 31st Annual European Society of Gene & Cell Therapy Congress
ORNA: Quarterly rpt on consolidated results for the financial period ended 30/06/2024
'Couples Therapy' Host Orna Guralnik Doesn't Think You Need to Go to Therapy
Orna Therapeutics Appoints Nobel Laureate Carolyn Bertozzi, Ph.D., to Scientific Advisory Board
No Data
No Data